A cancer researcher found guilty of misconduct has reached a settlement with the ORI that allows him to apply for federal research funding.
The Scientist
Most Recent
A researcher working for a US pharmaceutical company’s Scotland branch is sent to prison for falsifying safety test data on experimental drugs due for clinical trials.
A former University of Washington researcher did commit misconduct 10 years ago, according to the Office of Research Integrity.
Researchers develop two small molecules that slow the growth of human cancer cells.
A Japanese newspaper claims that the pharma giant funded flawed research that revealed extra health benefits for one of its top-selling drugs.
Researchers responding to a survey at MD Anderson Cancer Center report low morale due to their president’s leadership style.
Satellites of the Golgi apparatus generate the microtubules used to grow outer dendrite branches in Drosophila neurons.
Histone acetylation levels keep intracellular pH in check.
Nanoparticles coated with a toxin found in bee venom can destroy HIV while leaving surrounding cells intact.
Using plagiarism detection software, the NSF’s internal watchdog has found almost 100 suspicious cases among the 8,000 projects the agency funded in 2011.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
